ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway

Hepatocellular carcinoma (HCC) has been extensively studied as one of the most aggressive tumors worldwide. However, its mortality rate remains high due to ideal diagnosis and treatment strategies. Uncovering novel genes with prognostic significance would shed light on improving the HCC patient’s ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qifan, Zhang, Yunbin, Sun, Shibo, Wang, Kai, Qian, Jianping, Cui, Zhonglin, Tao, Tao, Zhou, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791021/
https://www.ncbi.nlm.nih.gov/pubmed/33414412
http://dx.doi.org/10.1038/s41419-020-03291-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791021/
https://www.ncbi.nlm.nih.gov/pubmed/33414412
http://dx.doi.org/10.1038/s41419-020-03291-2

Ejemplares similares